3 active not recruiting, 1 completed, 1 terminated. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Active not recruiting 3, Completed 1, Terminated 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Metastatic Malignant Solid Neoplasm: new trials by email Literature Review of Metastatic Malignant Solid Neoplasm trials Research Report on Metastatic Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial Best Practice, Biospecimen Collection, Bone Metastases Treatment - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm | Phase 3 | Active not recruiting | NRG Oncology | 280 | 2025-05-07 | 2026-08-17 |
| Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain Computed Tomography, Fractionated Stereotactic Radiation Therapy, Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 3 | Active not recruiting | NRG Oncology | 274 | 2024-12-12 | 2026-09-14 |
| Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma | Phase 3 | Terminated | NRG Oncology | 19 | 2021-08-05 | 2026-05-20 |
| Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 2 / Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 100 | 2019-03-30 | 2026-08-11 |
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Apixaban - Cerebral Vein Thrombosis, Deep Vein Thrombosis | Phase 3 | Completed | Academic and Community Cancer Research United | 370 | 2017-07-14 | 2025-05-18 |
Neoplasm Metastasis (5) · Brain Neoplasms (2) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Carcinoma, Renal Cell (2) · Lung Neoplasms (2) · Melanoma (2) · Gastrointestinal Neoplasms (1) · Hematologic Neoplasms (1) · Intracranial Thrombosis (1) · Pulmonary Embolism (1) · Small Cell Lung Carcinoma (1) · Venous Thrombosis (1)
Neoplasms (5) · Neoplastic Processes (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Brain Diseases (3) · Central Nervous System Diseases (3) · Lung Diseases (3) · Neoplasms by Site (3) · Nervous System Diseases (3) · Respiratory Tract Diseases (3) · Adenocarcinoma (2) · Breast Diseases (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2)
Magnetic Resonance Spectroscopy (3) · Radiosurgery (3) · Specimen Handling (2) · Memantine (1) · Observation (1) · Practice Guidelines as Topic (1) · Radiation (1) · Standard of Care (1) · Waiting Lists (1) · Watchful Waiting (1) · apixaban (1)
NRG Oncology (3) · Academic and Community Cancer Research United (1) · M.D. Anderson Cancer Center (1)
United States (5) · Canada (3) · Hong Kong (2) · Ireland (1)
Erin F Gillespie (1) · Robert D McBane (1) · Rupesh R Kotecha (1) · Sriram Yennu (1) · Vinai Gondi (1)
PMID 31606897, PMID 38537780, PMID 41825136
U10CA180868 (2), P30CA015083 (1), UG1CA189867 (1)